Schmitt M - Search Results

1

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread.

Sato S, Kopitz C, Schmalix WA, Muehlenweg B, Kessler H, Schmitt M, Krüger A, Magdolen V. Sato S, et al. Among authors: schmitt m. FEBS Lett. 2002 Sep 25;528(1-3):212-6. doi: 10.1016/s0014-5793(02)03311-2. FEBS Lett. 2002. PMID: 12297307 Free article.

2

Tumor-associated urokinase-type plasminogen activator: biological and clinical significance.

Schmitt M, Jänicke F, Moniwa N, Chucholowski N, Pache L, Graeff H. Schmitt M, et al. Biol Chem Hoppe Seyler. 1992 Jul;373(7):611-22. doi: 10.1515/bchm3.1992.373.2.611. Biol Chem Hoppe Seyler. 1992. PMID: 1515091 Review.

3

Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.

Goretzki L, Schmitt M, Mann K, Calvete J, Chucholowski N, Kramer M, Günzler WA, Jänicke F, Graeff H. Goretzki L, et al. Among authors: schmitt m. FEBS Lett. 1992 Feb 3;297(1-2):112-8. doi: 10.1016/0014-5793(92)80339-i. FEBS Lett. 1992. PMID: 1551416 Free article.

4

Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.

Schmitt M, Chucholowski N, Busch E, Hellmann D, Wagner B, Goretzki L, Jänicke F, Günzler WA, Graeff H. Schmitt M, et al. Semin Thromb Hemost. 1991 Jul;17(3):291-302. doi: 10.1055/s-2007-1002623. Semin Thromb Hemost. 1991. PMID: 1724574

5

Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer.

Schmitt M, Goretzki L, Jänicke F, Calvete J, Eulitz M, Kobayashi H, Chucholowski N, Graeff H. Schmitt M, et al. Biomed Biochim Acta. 1991;50(4-6):731-41. Biomed Biochim Acta. 1991. PMID: 1801751

6

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).

Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, Günzler WA, Jänicke F, Graeff H. Kobayashi H, et al. Among authors: schmitt m. J Biol Chem. 1991 Mar 15;266(8):5147-52. J Biol Chem. 1991. PMID: 1900515 Free article.

7

Elastase released from human granulocytes stimulated with N-formyl-chemotactic peptide prevents activation of tumor cell prourokinase (pro-uPA).

Schmitt M, Kanayama N, Henschen A, Hollrieder A, Hafter R, Gulba D, Jänicke F, Graeff H. Schmitt M, et al. FEBS Lett. 1989 Sep 11;255(1):83-8. doi: 10.1016/0014-5793(89)81065-8. FEBS Lett. 1989. PMID: 2529137 Free article.

8

Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

Reuning U, Wilhelm O, Nishiguchi T, Guerrini L, Blasi F, Graeff H, Schmitt M. Reuning U, et al. Among authors: schmitt m. Nucleic Acids Res. 1995 Oct 11;23(19):3887-93. doi: 10.1093/nar/23.19.3887. Nucleic Acids Res. 1995. PMID: 7479032 Free PMC article.

9

Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.

Wilhelm O, Schmitt M, Höhl S, Senekowitsch R, Graeff H. Wilhelm O, et al. Among authors: schmitt m. Clin Exp Metastasis. 1995 Jul;13(4):296-302. doi: 10.1007/BF00133485. Clin Exp Metastasis. 1995. PMID: 7606892

10

Selection of specific gene probes by combined use of low-stringency PCR amplification and Southern-blot hybridization.

Magdolen U, Magdolen V, Schmitt M, Bandlow W. Magdolen U, et al. Among authors: schmitt m. Curr Genet. 1995 Mar;27(4):390-2. doi: 10.1007/BF00352110. Curr Genet. 1995. PMID: 7614564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,004 results

Search Page

Filters